+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 22Years - 59Years
All Genders
Healthy Volunteers
ID07507903

Evaluation of the Accuracy and Safety of the Aktiia Optical Blood Pressure Monitoring Device at the Wrist Compared to Double Auscultation in Adults with Hypertension

Led by Aktiia SA · Updated on 2026-09-14

200

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the accuracy and precision of blood pressure and pulse rate measurements generated by the Aktiia Periodic Optical Blood Pressure Monitoring Device Aktiia.product-G1-US worn on the wrist. This study includes a minimum of 85 participants representative of the US population, aged 22 to 59 years, to assess device performance over a period of up to 7 days after initial use. The study is interventional and sponsored by Aktiia SA. Participants will have their blood pressure and pulse rate measured at multiple timepoints using the Aktiia device and reference methods, including double auscultation with a cuff for blood pressure and an electrocardiogram for pulse rate. The study spans 3 visits across 7 days, focusing on evaluating the devices measurement accuracy compared to these references. During the study, participants will attend several visits where blood pressure and pulse rate readings will be taken, and adherence to study procedures will be monitored. Researchers will analyze differences in blood pressure averages and variability over 7 days, as well as heart rate measurement errors. The total study duration is one week, with safety and performance data collected throughout this period.

CONDITIONS

Brief Title

OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device

Research Team

A

Anne Fedor Chief Clinical Research Officer

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here